A child watches as a nurse administers a shot of COVID-19 vaccine during a pop-up vaccination event at Lynn Family Stadium on April 26, 2021 in Louisville, Kentucky.
Jon Cherry | Getty Images
Top U.S. health officials believe that Pfizer‘s Covid-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday.
The timeline is based on the expectation that Pfizer, which developed the shot with Germany’s BioNTech, will have enough data from clinical trials to seek emergency use authorization (EUA) for that age group from the U.S. Food and Drug Administration towards the end of this month, the sources said.
They anticipate the FDA could make a decision on whether the shot is safe and effective in younger children within three weeks of the EUA submission.